Menu Search
Equities

Demant A/S

DEMANT:CPH

Demant A/S

Actions
Health CareMedical Equipment and Services
  • Price (DKK)336.00
  • Today's Change5.00 / 1.51%
  • Shares traded118.71k
  • 1 Year change+19.83%
  • Beta1.5353
Data delayed at least 15 minutes, as of May 17 2024 12:36 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 18-May-23
  • 15-Feb-24
  • 14-Mar-24
  • 18-Apr-24
  • 09-May-24
Select bar for recommendation details.
Recommendations09-May-24
Buy1
Outperform6
Hold6
Underperform4
Sell2

Share price forecast in DKK

The 17 analysts offering 12 month price targets for Demant A/S have a median target of 345.00, with a high estimate of 400.00 and a low estimate of 240.00. The median estimate represents a 4.23% increase from the last price of 331.00.
High20.8%400.00
Med4.2%345.00
Low-27.5%240.00

Earnings history & estimates in DKK

Demant A/S reported annual 2023 earnings of 8.04 per share on Feb 05, 2024.
Average growth rate+20.00%
More ▼

Revenue history & estimates in DKK

Demant A/S had revenues for the full year 2023 of 22.44bn. This was 13.89% above the prior year's results.
Average growth rate+11.25%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.